Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8904)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2016 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ghiringhelli F, Richard C, Chevrier S, Végran F, Boidot R. Efficiency of olaparib in colorectal cancer patients with an alteration of the homologous repair protein. World J Gastroenterol 2016; 22(48): 10680-10686 [PMID: 28082821 DOI: 10.3748/wjg.v22.i48.10680] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i48/10680.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Su-Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming-Shen Dai, Chuan-Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O’Shaughnessy, Judith Balmaña. Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast Cancer 2022; 29(1): 92 doi: 10.1007/s12282-021-01283-4
|
| 3 |
Jennifer M. J. Jongen, Lizet M. van der Waals, Kari Trumpi, Jamila Laoukili, Niek A. Peters, Susanne J. Schenning-van Schelven, Klaas M. Govaert, Inne H. M. Borel Rinkes, Onno Kranenburg. Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability. Oncotarget 2017; 8(49): 86296 doi: 10.18632/oncotarget.21145
|
| 4 |
Gloria Ravegnini, Giorgia Valori, Qianqian Zhang, Riccardo Ricci, Patrizia Hrelia, Sabrina Angelini. Pharmacogenetics in the treatment of gastrointestinal stromal tumors – an updated review. Expert Opinion on Drug Metabolism & Toxicology 2020; 16(9): 797 doi: 10.1080/17425255.2020.1789589
|
| 5 |
Minyi Lee, George Eng, Stephanie R. Barbari, Vikram Deshpande, Polina V. Shcherbakova, Manish K. Gala. Homologous Recombination Repair Truncations Predict Hypermutation in Microsatellite Stable Colorectal and Endometrial Tumors. Clinical and Translational Gastroenterology 2020; 11(3): e00149 doi: 10.14309/ctg.0000000000000149
|
| 6 |
S. Joris, H. Denys, J. Collignon, M. Rasschaert, D. T’Kint de Roodenbeke, F.P. Duhoux, J.-L. Canon, S. Tejpar, J. Mebis, L. Decoster, P. Aftimos, J. De Grève. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO Open 2023; 8(6): 102041 doi: 10.1016/j.esmoop.2023.102041
|
| 7 |
Pedro L.S. Uson, Douglas Riegert-Johnson, Lisa Boardman, John Kisiel, Luke Mountjoy, Neej Patel, Blanca Lizaola-Mayo, Mitesh J. Borad, Daniel Ahn, Mohamad B. Sonbol, Jeremy Jones, Jonathan A. Leighton, Suryakanth Gurudu, Harminder Singh, Margaret Klint, Katie L. Kunze, Michael A. Golafshar, Ed D. Esplin, Robert L. Nussbaum, A. Keith Stewart, Tanio S. Bekaii-Saab, Niloy Jewel Samadder. Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study. Clinical Gastroenterology and Hepatology 2022; 20(3): e508 doi: 10.1016/j.cgh.2021.04.013
|
| 8 |
Minghan Song, Xianrong Zeng, Qian Wu, Jie Huang, Jiayi Dong, Lijuan Shao, Zihao Sun, Yiguang Lin, Size Chen. Metastatic Colorectal Cancer Patient with Microsatellite Stability and Germline BRAC2 Mutation Shows a Complete Response to Olaparib in Combination with a PD-1 Inhibitor and Bevacizumab: A Case Report and Review of the Literature. Life 2023; 13(5): 1183 doi: 10.3390/life13051183
|
| 9 |
Sandy Chevrier, Corentin Richard, Thomas Collot, Hugo Mananet, Laurent Arnould, Romain Boidot. An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers. Cancers 2021; 13(13): 3113 doi: 10.3390/cancers13133113
|
| 10 |
Natalie Y.L. Ngoi, Darwin Tay, Valerie Heong, Yee Liang Thian, Pei Yi Ong, Samuel G.W. Ow, Anand D. Jeyasekharan, Yi Wan Lim, Siew Eng Lim, Soo Chin Lee, Joseph Ng, Jeffrey J.H. Low, Arunachalam Ilancheran, Sharon Z.L. Koh, David S.P. Tan. Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation–Associated Ovarian Cancer. JCO Precision Oncology 2018; (2): 1 doi: 10.1200/PO.18.00008
|
| 11 |
Nicole M. Reilly, Luca Novara, Federica Di Nicolantonio, Alberto Bardelli. Exploiting DNA repair defects in colorectal cancer. Molecular Oncology 2019; 13(4): 681 doi: 10.1002/1878-0261.12467
|
| 12 |
Nikolaos Skouteris, Georgios Papageorgiou. PARP Inhibitors in Colorectal Malignancies: A 2023 Update. Reviews on Recent Clinical Trials 2024; 19(2): 101 doi: 10.2174/0115748871260815231116060817
|
| 13 |
Pi-Yueh Chang, Shih-Cheng Chang, Mei-Chia Wang, Jinn-Shiun Chen, Wen-Sy Tsai, Jeng-Fu You, Chia-Chun Chen, Hsiu-Ling Liu, Jy-Ming Chiang. Pathogenic Germline Mutations of DNA Repair Pathway Components in Early-Onset Sporadic Colorectal Polyp and Cancer Patients. Cancers 2020; 12(12): 3560 doi: 10.3390/cancers12123560
|
| 14 |
Ryan S. Nelson, Rutika J. Mehta, Howard L. McLeod, Christine M. Walko. Prioritization of Therapy Options for a Patient With High Tumor Mutation Burden and Microsatellite Instability but No Clinical Benefit From Immunotherapy. JCO Precision Oncology 2019; (3): 1 doi: 10.1200/PO.19.00197
|
| 15 |
Pavel Vodicka, Marketa Urbanova, Pavol Makovicky, Kristyna Tomasova, Michal Kroupa, Rudolf Stetina, Alena Opattova, Klara Kostovcikova, Anna Siskova, Michaela Schneiderova, Veronika Vymetalkova, Ludmila Vodickova. Oxidative Damage in Sporadic Colorectal Cancer: Molecular Mapping of Base Excision Repair Glycosylases in Colorectal Cancer Patients. International Journal of Molecular Sciences 2020; 21(7): 2473 doi: 10.3390/ijms21072473
|
| 16 |
Georgios I. Papageorgiou, Evangelos Fergadis, Nikos Skouteris, Evridiki Christakos, Sergios A. Tsakatikas, Evangelos Lianos, Christos Kosmas. Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.788809
|